Cargando…
The influence of tamoxifen on normal mouse mammary gland homeostasis
INTRODUCTION: Lineage tracing using inducible genetic labeling has emerged to be a powerful method for interrogating the developmental fate of cells in intact tissues. A common induction mechanism is the use of tamoxifen-dependent Cre recombinase (CreER and CreER(T2)), but the effects of tamoxifen a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303226/ https://www.ncbi.nlm.nih.gov/pubmed/25056669 http://dx.doi.org/10.1186/s13058-014-0411-0 |
_version_ | 1782353911304159232 |
---|---|
author | Shehata, Mona van Amerongen, Renée Zeeman, Amber L Giraddi, Rajshekhar R Stingl, John |
author_facet | Shehata, Mona van Amerongen, Renée Zeeman, Amber L Giraddi, Rajshekhar R Stingl, John |
author_sort | Shehata, Mona |
collection | PubMed |
description | INTRODUCTION: Lineage tracing using inducible genetic labeling has emerged to be a powerful method for interrogating the developmental fate of cells in intact tissues. A common induction mechanism is the use of tamoxifen-dependent Cre recombinase (CreER and CreER(T2)), but the effects of tamoxifen at doses normally used in lineage-tracing studies on normal adult mammary gland homeostasis are not known. METHODS: We used flow cytometry and immunostaining of intact glands to determine whether varying doses of tamoxifen skew the distribution and the apoptosis and proliferation status of different types of mammary epithelial cells in vivo. We also examined how tamoxifen influences the number of progenitor and mammary repopulating units (MRUs). RESULTS: Our results indicate that ≥5 mg/25 g body weight of tamoxifen induces a transient increase in cell proliferation and in the number of basal cells in the adult mammary epithelium up to 7 days after tamoxifen administration. However, in the medium term (3 weeks), all doses of tamoxifen ≥1 mg/25 g body weight result in a decrease in the number of basal and EpCAM(+)CD49b(−) luminal cells and a decrease in progenitor cell function. Tamoxifen at doses ≥5 mg/25 g body weight induced a transient increase in caspase-3-mediated apoptotic cell death within the mammary epithelium. However, mammary epithelial cell numbers in all subpopulations were restored to their original levels by 8 weeks. No long-lasting effects of tamoxifen on MRU numbers or on pubertal ductal development were observed. CONCLUSION: Tamoxifen can skew the distribution of mammary cell types in a dose-dependent manner, and thus caution must be taken when interpreting lineage-tracing studies using high doses of tamoxifen, particularly when short-duration analyses of a quantitative nature are being performed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0411-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4303226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43032262015-01-23 The influence of tamoxifen on normal mouse mammary gland homeostasis Shehata, Mona van Amerongen, Renée Zeeman, Amber L Giraddi, Rajshekhar R Stingl, John Breast Cancer Res Research Article INTRODUCTION: Lineage tracing using inducible genetic labeling has emerged to be a powerful method for interrogating the developmental fate of cells in intact tissues. A common induction mechanism is the use of tamoxifen-dependent Cre recombinase (CreER and CreER(T2)), but the effects of tamoxifen at doses normally used in lineage-tracing studies on normal adult mammary gland homeostasis are not known. METHODS: We used flow cytometry and immunostaining of intact glands to determine whether varying doses of tamoxifen skew the distribution and the apoptosis and proliferation status of different types of mammary epithelial cells in vivo. We also examined how tamoxifen influences the number of progenitor and mammary repopulating units (MRUs). RESULTS: Our results indicate that ≥5 mg/25 g body weight of tamoxifen induces a transient increase in cell proliferation and in the number of basal cells in the adult mammary epithelium up to 7 days after tamoxifen administration. However, in the medium term (3 weeks), all doses of tamoxifen ≥1 mg/25 g body weight result in a decrease in the number of basal and EpCAM(+)CD49b(−) luminal cells and a decrease in progenitor cell function. Tamoxifen at doses ≥5 mg/25 g body weight induced a transient increase in caspase-3-mediated apoptotic cell death within the mammary epithelium. However, mammary epithelial cell numbers in all subpopulations were restored to their original levels by 8 weeks. No long-lasting effects of tamoxifen on MRU numbers or on pubertal ductal development were observed. CONCLUSION: Tamoxifen can skew the distribution of mammary cell types in a dose-dependent manner, and thus caution must be taken when interpreting lineage-tracing studies using high doses of tamoxifen, particularly when short-duration analyses of a quantitative nature are being performed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0411-0) contains supplementary material, which is available to authorized users. BioMed Central 2014-07-24 2014 /pmc/articles/PMC4303226/ /pubmed/25056669 http://dx.doi.org/10.1186/s13058-014-0411-0 Text en © Shehata et al.; licensee BioMed Central 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Shehata, Mona van Amerongen, Renée Zeeman, Amber L Giraddi, Rajshekhar R Stingl, John The influence of tamoxifen on normal mouse mammary gland homeostasis |
title | The influence of tamoxifen on normal mouse mammary gland homeostasis |
title_full | The influence of tamoxifen on normal mouse mammary gland homeostasis |
title_fullStr | The influence of tamoxifen on normal mouse mammary gland homeostasis |
title_full_unstemmed | The influence of tamoxifen on normal mouse mammary gland homeostasis |
title_short | The influence of tamoxifen on normal mouse mammary gland homeostasis |
title_sort | influence of tamoxifen on normal mouse mammary gland homeostasis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303226/ https://www.ncbi.nlm.nih.gov/pubmed/25056669 http://dx.doi.org/10.1186/s13058-014-0411-0 |
work_keys_str_mv | AT shehatamona theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis AT vanamerongenrenee theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis AT zeemanamberl theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis AT giraddirajshekharr theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis AT stingljohn theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis AT shehatamona influenceoftamoxifenonnormalmousemammaryglandhomeostasis AT vanamerongenrenee influenceoftamoxifenonnormalmousemammaryglandhomeostasis AT zeemanamberl influenceoftamoxifenonnormalmousemammaryglandhomeostasis AT giraddirajshekharr influenceoftamoxifenonnormalmousemammaryglandhomeostasis AT stingljohn influenceoftamoxifenonnormalmousemammaryglandhomeostasis |